Ctrl+Alt+Cure: Driving Smarter Cancer Care

June 11, 2025 11:00 a.m. - 12:00 p.m. ET
Virtual

Join Dr. Douglas Flora, executive medical director of Oncology Services at St. Elizabeth Healthcare, to explore how artificial intelligence (AI) is revolutionizing cancer care through oncology. This event will cover:

  • key AI terminology,
  • the history and role of AI in oncology,
  • AI’s impact on clinical development and diagnostics,
  • AI’s applications in drug discovery and development,
  • AI’s impact on clinical research, and
  • the future of AI and potential concerns.

The CBIIT Data Science Seminar Series is dedicating its 2025 events to spotlighting the use of AI in cancer research and care. Brought to you by CBIIT and NCI’s Division of Cancer Treatment and Diagnosis AI working group, the upcoming webinars will explore a variety of questions, such as the following:

  • How can AI be used for diagnosis, treatment, diagnosis, or omics research?
  • What are the related laws and ethical considerations for AI?
  • How can we empower an AI-ready cancer research community through workforce development, collaborations, and funding?

To view upcoming speakers or recordings of past presentations, visit the CBIIT Data Science Seminar Series webpage.

Douglas Flora, M.D., LSSBB

Dr. Flora serves as the executive medical director of Oncology Services at St. Elizabeth Healthcare. Additionally, he is the editor-in-chief of the peer-reviewed research journal AI in Precision Oncology, and he holds the Robert and Dell Ann Sathe Endowed Chair.

Vote below about this page’s helpfulness.